Talwar GP - Search Results

1

Survivin: a unique target for tumor therapy.

Garg H, Suri P, Gupta JC, Talwar GP, Dubey S. Garg H, et al. Among authors: talwar gp. Cancer Cell Int. 2016 Jun 23;16:49. doi: 10.1186/s12935-016-0326-1. eCollection 2016. Cancer Cell Int. 2016. PMID: 27340370 Free PMC article. Review.

2

Immunological approaches against human chorionic gonadotropin for control of fertility and therapy of advanced-stage cancers expressing hCG/subunits.

Talwar GP, Gupta JC, Shankar NV. Talwar GP, et al. Am J Reprod Immunol. 2011 Jul;66(1):26-39. doi: 10.1111/j.1600-0897.2011.01002.x. Epub 2011 Apr 19. Am J Reprod Immunol. 2011. PMID: 21501278 Review.

3

Immunotherapy approach with recombinant survivin adjuvanted with alum and MIP suppresses tumor growth in murine model of breast cancer.

Garg H, Gupta JC, Talwar GP, Dubey S. Garg H, et al. Among authors: talwar gp. Prep Biochem Biotechnol. 2018 Mar 16;48(3):264-269. doi: 10.1080/10826068.2018.1425710. Epub 2018 Feb 20. Prep Biochem Biotechnol. 2018. PMID: 29355462

4

Combination immunotherapy with Survivin and luteinizing hormone-releasing hormone fusion protein in murine breast cancer model.

Garg H, Hada RS, Gupta JC, Talwar GP, Dubey S. Garg H, et al. Among authors: talwar gp. World J Clin Oncol. 2018 Dec 20;9(8):188-199. doi: 10.5306/wjco.v9.i8.188. World J Clin Oncol. 2018. PMID: 30622927 Free PMC article.

5

Gonadotropin-releasing hormone/human chorionic gonadotropin beta based recombinant antibodies and vaccines.

Talwar GP, Vyas HK, Purswani S, Gupta JC. Talwar GP, et al. J Reprod Immunol. 2009 Dec;83(1-2):158-63. doi: 10.1016/j.jri.2009.08.008. Epub 2009 Oct 24. J Reprod Immunol. 2009. PMID: 19854518 Review.

6

Development of a novel recombinant LHRH fusion protein for therapy of androgen and estrogen dependent cancers.

Gupta JC, Hada RS, Sahai P, Talwar GP. Gupta JC, et al. Among authors: talwar gp. Protein Expr Purif. 2017 Jun;134:132-138. doi: 10.1016/j.pep.2017.04.003. Epub 2017 Apr 12. Protein Expr Purif. 2017. PMID: 28410993

7

Current status of a unique vaccine preventing pregnancy.

Talwar GP, Nand KN, Gupta JC, Bandivdekar AH, Sharma RS, Lohiya NK. Talwar GP, et al. Front Biosci (Elite Ed). 2017 Jun 1;9(2):321-332. doi: 10.2741/e805. Front Biosci (Elite Ed). 2017. PMID: 28410154 Free article.

8

Priming with DNA Enhances Considerably the Immunogenicity of hCG β-LTB Vaccine.

Nand KN, Gupta JC, Panda AK, Jain SK, Talwar GP. Nand KN, et al. Among authors: talwar gp. Am J Reprod Immunol. 2015 Oct;74(4):302-8. doi: 10.1111/aji.12388. Epub 2015 Apr 28. Am J Reprod Immunol. 2015. PMID: 25917014

9

Advances in development of a contraceptive vaccine against human chorionic gonadotropin.

Talwar GP, Gupta JC, Rulli SB, Sharma RS, Nand KN, Bandivdekar AH, Atrey N, Singh P. Talwar GP, et al. Expert Opin Biol Ther. 2015;15(8):1183-90. doi: 10.1517/14712598.2015.1049943. Expert Opin Biol Ther. 2015. PMID: 26160491 Review.

10

A recombinant luteinising-hormone-releasing-hormone immunogen bioeffective in causing prostatic atrophy.

Talwar GP, Raina K, Gupta JC, Ray R, Wadhwa S, Ali MM. Talwar GP, et al. Vaccine. 2004 Sep 9;22(27-28):3713-21. doi: 10.1016/j.vaccine.2004.03.014. Vaccine. 2004. PMID: 15315851

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

405 results

Search Page